Physician profile
Daniel Ojala
NPI 1104387810
$1,880.70
in general payments reported to CMS, 2019-2025
8 companies · $1,701 in 2025
The $1,701 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.41 · 2023: $74.66 · 2024: $92.26 · 2025: $1,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354 · Travel and Lodging: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.82 |
| Travel and Lodging | $514.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,572.71 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $97.99 | 2025 | Opdivo |
| Pacira Pharmaceuticals Incorporated | $78.84 | 2025 | Exparel |
| Boston Scientific Corporation | $31.61 | 2022-2023 | Spyglass Discover |
| Dilon Technologies, INC. | $29.76 | 2023 | Hemoblast Bellows |
| Medtronic, INC. | $25.70 | 2023 | Signia |
| Davol INC. | $23.26 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $20.83 | 2025 | Surgicel Nu-Knit, Stratafix, Evarrest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ojala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.